Recent Insider Transactions - Aurinia Pharmaceuticals (NASDAQ: AUPH)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ AUPH Aurinia Pharmaceuticals

TANG KEVIN / director

12/09/2024

Buy

$9.09

500,000

$4.545M

8.43M

NASDAQ AUPH Aurinia Pharmaceuticals

TANG KEVIN / director

12/06/2024

Buy

$9.01

400,000

$3.604M

7.93M

NASDAQ AUPH Aurinia Pharmaceuticals

TANG KEVIN / director

12/05/2024

Buy

$8.91

300,000

$2.673M

7.53M

NASDAQ AUPH Aurinia Pharmaceuticals

Smith Karen L. / director

11/21/2024

Buy

$8.24

18,641

$154K

18,641

NASDAQ AUPH Aurinia Pharmaceuticals

Leversage Jill / director

11/21/2024

Buy

$8.24

18,641

$154K

18,641

NASDAQ AUPH Aurinia Pharmaceuticals

Johnson Craig A / director

11/21/2024

Buy

$8.24

31,688

$261K

31,688

NASDAQ AUPH Aurinia Pharmaceuticals

Bailey Jeffrey Allen / director

11/21/2024

Buy

$8.24

18,641

$154K

18,641

NASDAQ AUPH Aurinia Pharmaceuticals

Jayne David R.W. / director

11/21/2024

Buy

$8.24

18,641

$154K

18,641

NASDAQ AUPH Aurinia Pharmaceuticals

Bailey Jeffrey Allen / director

11/11/2024

Sell

$8.43

4,557

$38K

13,356

NASDAQ AUPH Aurinia Pharmaceuticals

Smith Karen L. / director

11/11/2024

Sell

$8.43

5,241

$44K

12,672

NASDAQ AUPH Aurinia Pharmaceuticals

Keenan Greg / officer: Chief Medical Officer

11/07/2024

Sell

$8.99

81,990

$737K